The global CAR T-cell therapy market is witnessing exponential growth, driven by increasing occurrence of cancer and favorable regulatory policies. Leading players in the market are engaging in innovation to broaden their product portfolio and meet the growing demand for effective cancer treatments. Additionally, advancements in CAR T-cell therapy